China Biotech Services Holdings Limited

Simbol: 8037.HK

HKSE

0.305

HKD

Tržna cena danes

  • -2.3428

    Razmerje P/E

  • 0.0000

    Razmerje PEG

  • 293.79M

    Kapaciteta MRK

  • 0.03%

    Donos DIV

China Biotech Services Holdings Limited (8037-HK) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za China Biotech Services Holdings Limited (8037.HK). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja China Biotech Services Holdings Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

0206.992.8152.3
385.8
46.8
157
76.1
88.5
130
57.9
105
63.9
107.9
7.8
11.8
11.1
28.8
34.7

balance-sheet.row.short-term-investments

00-128.61.8
1.3
1.3
2.6
3
53.8
54.8
18.7
66.7
38.8
19.5
5.7
0
0
0
0

balance-sheet.row.net-receivables

039.2768.5117.6
52.9
32.6
0
0
0
0
0
0
0
46.9
48.9
67.3
61.9
73.3
59.4

balance-sheet.row.inventory

09.318.74.7
5.5
3.4
3.5
6.6
7.4
9.7
63.9
44.3
46.4
36.1
35.6
89
91.4
91.5
85.7

balance-sheet.row.other-current-assets

05.84.83.1
2.1
3.6
57.4
99.2
50
194.8
107
23
49.5
0.1
0.3
3.9
9.6
5.1
1.8

balance-sheet.row.total-current-assets

0261.2884.8277.8
446.3
86.4
218
182
146
334.5
228.7
172.2
159.8
191
92.6
172.1
174.1
198.7
181.5

balance-sheet.row.property-plant-equipment-net

0124.2128.9105.5
147.7
36.9
23
41.4
41.4
31
46.8
14.2
29
45
46.3
52.5
50.2
48.2
25.2

balance-sheet.row.goodwill

0107.2110.1120.6
117.6
115.3
0.3
0.3
1.7
29.4
2.5
0
0
0
0
5.6
5.5
5.5
0

balance-sheet.row.intangible-assets

069.867.380.9
88.1
95.3
43.4
52.8
64.5
67.2
26.1
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0177177.4201.5
205.7
210.6
43.7
53.1
66.2
96.6
28.5
0
0
0
0
5.6
5.5
5.5
0

balance-sheet.row.long-term-investments

056.9227.7120.3
97.6
81.3
50.6
23.9
15.5
-38.9
4.3
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

057.6-227.70
0
0
46.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0-14.6279.51.8
6.9
1.3
-43.7
3
53.8
54.8
18.7
4.6
7
11.5
16.2
18.1
15.2
14.4
8.2

balance-sheet.row.total-non-current-assets

0401.2585.7429
457.8
330.1
119.8
121.4
177
143.5
98.3
18.7
36
56.5
62.5
76.3
71
68.1
33.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0662.41470.5706.8
904.1
416.6
337.8
303.4
323
478
327
190.9
195.8
247.5
155.1
248.3
245
266.8
214.9

balance-sheet.row.account-payables

05.8206.416.1
190.2
3.4
2.2
5.1
8.4
4.3
21
8.6
22.7
19.5
36.9
75.7
71
28.3
12.2

balance-sheet.row.short-term-debt

094.716.663.6
23.3
36.1
3.3
26.8
18.9
1.9
19
12.2
22.2
18.1
20.3
34.5
26.9
5.9
14

balance-sheet.row.tax-payables

03.724285.2
36
0.3
0
0.5
0
0.1
0
0
0.1
0
0
0.6
0.5
0.5
1.6

balance-sheet.row.long-term-debt-total

05.765.23.6
83.1
6.1
1.6
4.8
3.1
0
0
0
0
0
3.1
3.1
0
0
0

Deferred Revenue Non Current

0-5.70-9.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

058.6325.223.7
58.8
14.2
10.4
13.9
15.6
127.1
89
14.6
53.2
63.1
45.6
0.6
0.5
40.1
24.8

balance-sheet.row.total-non-current-liabilities

012.295.313.5
119.7
49.5
3
6.4
4.9
2
40.1
20.9
44.9
37.7
3.1
-110.7
97.9
15.5
26.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
-40.1
-20.9
-44.9
-37.7
0
113.8
-97.9
0
-26.1

balance-sheet.row.capital-lease-obligations

05.720.311.1
19.4
13.4
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0171.6644240.9
392
103.2
18.8
52.1
47.7
135.3
129.1
84.1
98.1
100.8
105.9
113.8
98.4
89.8
51

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

096.396.396.3
96.7
97
93.5
85.6
78.8
65.7
10.1
115.2
96
96
53.3
0
0
0
0

balance-sheet.row.retained-earnings

0-310.8-209.9-475.1
-493.6
-531.1
0
-366.6
-303.6
-297.8
-235.5
0
-154.7
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0186.5225.6283.5
244.4
224.4
-21.9
-25.9
-23.3
0
0
-14.3
-24.4
-24.7
-25
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0490.7490.7490.7
495.8
498.9
252.4
561.5
513.5
553.2
394.8
5.6
178.4
70.7
14.6
127.1
141
171.6
164

balance-sheet.row.total-stockholders-equity

0462.8602.7395.4
343.3
289.2
324.1
254.7
265.5
321.1
169.3
106.5
95.3
142
43
127.1
141
171.6
164

balance-sheet.row.total-liabilities-and-stockholders-equity

0662.41470.5706.8
904.1
416.6
337.8
303.4
323
478
327
190.9
195.8
247.5
155.1
248.3
245
266.8
214.9

balance-sheet.row.minority-interest

028223.870.5
168.8
24.2
-5.2
-3.4
9.7
21.7
28.6
0.3
2.4
4.7
6.2
7.4
5.7
5.4
0

balance-sheet.row.total-equity

0490.7826.5465.9
512.1
313.4
318.9
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

056.999.2122
98.8
82.6
53.1
26.9
69.4
15.9
23
66.7
38.8
19.5
5.7
0
0
0
0

balance-sheet.row.total-debt

0100.481.867.2
106.3
42.2
4.9
31.5
22
1.9
19
12.2
22.2
18.1
23.4
37.5
26.9
5.9
14

balance-sheet.row.net-debt

0-106.5-11-83.4
-278.2
-3.3
-149.6
-41.6
-12.7
-73.3
-20.1
-26
-2.9
-70.3
21.2
25.8
15.7
-22.9
-20.7

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju China Biotech Services Holdings Limited opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420122011201020092008200720062005

cash-flows.row.net-income

0-95.4862.8180.7
202.8
-109.6
-69.2
-75.4
-59.6
-68.1
-82.3
-20.7
-45.6
-18
-83.4
-37.4
-38.3
0.5
25.2

cash-flows.row.depreciation-and-amortization

055.666.468.1
40.3
20.2
8.5
7.3
7.4
5.8
2.6
2.1
3.8
4.2
5.2
5.4
4.8
4
3.2

cash-flows.row.deferred-income-tax

0381.707.8
-3.9
33.4
-2.8
0
0
0
52.3
5.2
0
18.2
0
0
0
0
0

cash-flows.row.stock-based-compensation

01.925.2
9.1
10.5
12.3
0
0
0
3.4
2.8
0
8.6
0
0
0
0
0

cash-flows.row.change-in-working-capital

0494.8-433.3-225.5
172.6
22.7
33.1
-27.4
1
-50.8
-20.1
8.8
-27.2
-16.2
42.1
-1.9
1.7
2.6
-15.5

cash-flows.row.account-receivables

0729.9-656.4-64.9
-22.2
20.6
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2.2-14-2.4
-2.5
-0.1
-0.5
-0.4
8.6
-5.1
-15
1.8
-13.3
-13.9
23.5
4.8
-10.4
-12.2
-17.6

cash-flows.row.account-payables

0-232.9237.1-158.3
197.4
2.2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
33.6
-27
-7.6
-45.6
-5.1
7
-14
-2.3
18.6
-6.7
12.1
14.8
2.1

cash-flows.row.other-non-cash-items

0-645.9-15.24.2
1
-7.5
3.5
38.6
25.7
28
4.2
0.2
42
1.8
44.5
13.3
13.3
15.7
5.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-62.9-69.8-12.2
-126.6
-7.4
-6.5
-5.1
-8.2
-9.8
-2.8
-0.8
-2.6
-5.9
-3.1
-7
-5.6
-9.2
-1.2

cash-flows.row.acquisitions-net

07.5-6.50.5
0.1
-54.7
2.1
41.2
-43.2
-92
-30.7
0
7.2
0
0.2
-0.3
0
-24.8
0

cash-flows.row.purchases-of-investments

00-51.8-0.5
0
-39.2
-39.3
-5
-20.2
-3.6
0
0
0
-19.9
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

000.14.1
0
0
2.2
0.1
4.8
0.5
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

00-128.40
0.2
1
5
10
10.5
9
0.2
-13.1
-39.6
21.2
2.2
9
-4.5
-4.2
-6

cash-flows.row.net-cash-used-for-investing-activites

0-55.4-256.3-8.1
-126.2
-100.2
-36.5
41.2
-56.3
-96
-33.3
-13.9
-35
-4.5
-0.7
1.7
-10.1
-38.3
-7.1

cash-flows.row.debt-repayment

0-31.1-8.2-52.2
-23.9
-5.7
-5.3
-3.1
-42.4
0
-50.1
-12.3
-18.1
-5.3
-14.1
-35.2
-24.9
-25.4
-9.4

cash-flows.row.common-stock-issued

0000
0.1
11.6
132.1
47.5
21.2
212.9
120.6
29
0
106.4
1.2
10.7
0
0
0

cash-flows.row.common-stock-repurchased

0-3.6-3-4.3
-4.5
-0.5
-0.9
0
0
0
0
0
0
0.1
0
0
0
0
0

cash-flows.row.dividends-paid

0-9.600
-0.1
-15.7
0
0
0
0
0
0
0
-1.7
-3.4
0
0
0
-14.5

cash-flows.row.other-financing-activites

0-156-270.8-210.1
72.4
33.4
6.7
7.6
60.1
4.5
13.4
12.1
18.8
-6.5
-0.4
42.3
29.9
33.6
12.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-149.4-282-266.6
43.9
23.1
132.6
52.1
39
217.4
84
28.8
0.6
92.9
-16.8
17.7
5
8.2
-11.6

cash-flows.row.effect-of-forex-changes-on-cash

0-2.2-2.30.2
-0.7
-1.5
0
2.2
-0.9
-0.8
0
0.1
-2
-0.5
-0.5
1.8
6
1.5
0

cash-flows.row.net-change-in-cash

0114.1-57.8-234
339
-109
81.3
38.5
-43.5
35.5
10.7
13.2
-63.4
86.3
-9.6
0.6
-17.6
-5.9
-0.2

cash-flows.row.cash-at-end-of-period

0206.992.8150.6
384.5
45.5
154.5
73.2
34.7
78.2
42.8
38.3
25.1
88.4
2.1
11.8
11.1
28.8
34.7

cash-flows.row.cash-at-beginning-of-period

092.8150.6384.5
45.5
154.5
73.2
34.7
78.2
42.8
32.1
25.1
88.4
2.1
11.8
11.1
28.8
34.7
34.8

cash-flows.row.operating-cash-flow

0192.6482.740.5
422
-30.3
-14.8
-57
-25.4
-85.1
-40
-1.6
-27
-1.5
8.4
-20.6
-18.5
22.7
18.6

cash-flows.row.capital-expenditure

0-62.9-69.8-12.2
-126.6
-7.4
-6.5
-5.1
-8.2
-9.8
-2.8
-0.8
-2.6
-5.9
-3.1
-7
-5.6
-9.2
-1.2

cash-flows.row.free-cash-flow

0129.741328.3
295.4
-37.7
-21.3
-62
-33.6
-95
-42.8
-2.4
-29.6
-7.4
5.2
-27.6
-24.1
13.5
17.4

Vrstica izkaza poslovnega izida

Prihodki China Biotech Services Holdings Limited so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 8037.HK znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420122011201020092008200720062005

income-statement-row.row.total-revenue

02121851.5623.8
655.8
59.2
70.3
105.1
86.6
34.1
140.4
101.4
45
84.2
160.5
272.3
270.8
243.4
197.5

income-statement-row.row.cost-of-revenue

0177.7750.6265.7
316.7
36.8
42.2
74.9
56.5
24.5
87.4
55.8
41.1
43.7
71.6
111.7
98
97.8
70.1

income-statement-row.row.gross-profit

034.31101358
339.1
22.4
28.1
30.2
30
9.6
52.9
45.6
3.9
40.5
88.9
160.6
172.7
145.6
127.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.6-3.40.7
-5
-0.1
0.2
0.4
0.7
0.3
1.7
0.4
-3.1
-7
-5.8
0.8
0.6
0.5
0.2

income-statement-row.row.operating-expenses

0158251.5168.8
139.3
106.4
95.4
71.4
75.1
43.9
80.6
58
46.4
54.7
128.1
194.7
209.1
145.1
102.3

income-statement-row.row.cost-and-expenses

0335.71002.1434.5
456
143.3
137.6
146.3
131.6
68.4
168
113.7
87.5
98.4
199.7
306.4
307.2
242.9
172.4

income-statement-row.row.interest-income

03.70.20
0
0.2
0
0.1
0.3
0.3
0.2
0.1
0.2
0
0
0
0
0
0

income-statement-row.row.interest-expense

05.33.56.5
6.5
1.7
3.5
2.2
2
0.4
4.4
3
3.3
1.7
3.4
1.8
-0.2
2.9
-0.7

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-10.711.1-8.8
2.2
-25.5
-1.9
-34.2
-50.1
-25.7
-54.7
-2.4
-3.1
-3.8
-44.3
-1.8
0.2
2.9
-0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.6-3.40.7
-5
-0.1
0.2
0.4
0.7
0.3
1.7
0.4
-3.1
-7
-5.8
0.8
0.6
0.5
0.2

income-statement-row.row.total-operating-expenses

0-10.711.1-8.8
2.2
-25.5
-1.9
-34.2
-50.1
-25.7
-54.7
-2.4
-3.1
-3.8
-44.3
-1.8
0.2
2.9
-0.5

income-statement-row.row.interest-expense

05.33.56.5
6.5
1.7
3.5
2.2
2
0.4
4.4
3
3.3
1.7
3.4
1.8
-0.2
2.9
-0.7

income-statement-row.row.depreciation-and-amortization

055.658.468.1
40.3
27.1
8.5
7.3
7.4
5.8
2.6
2.1
3.8
4.2
5.2
5.4
4.8
4
3.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-123.7851.7189.4
200.6
-84.1
-69.6
-73.3
-69.8
-50.3
-63.4
-11.8
-42.5
-16.3
-74.2
-34.1
-36.4
0.5
25.1

income-statement-row.row.income-before-tax

0-134.3862.8180.7
202.8
-109.6
-69.2
-75.4
-95.1
-60
-82.3
-14.8
-45.6
-18
-83.4
-35.9
-36.2
3.4
24.6

income-statement-row.row.income-tax-expense

0-1.3157.348.1
35.2
-2.1
0.2
1.1
0.5
-0.4
0.6
0.1
0.4
0
1
1.5
2.1
-2.9
0.6

income-statement-row.row.net-income

0-95.4705.6132.6
167.6
-107.5
-64.3
-63
-50.2
-62.3
-82.9
-20.7
-43.6
-16.5
-83.6
-37.4
-38.3
0.5
25.2

Pogosto zastavljeno vprašanje

Kaj je China Biotech Services Holdings Limited (8037.HK) skupna sredstva?

China Biotech Services Holdings Limited (8037.HK) skupna sredstva so 662362000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.100.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.200.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.535.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.796.

Kaj je China Biotech Services Holdings Limited (8037.HK) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -95447000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 100396000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 158009000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.